Validation of a claims-based antipsychotic polypharmacy measure()

PURPOSE: Given the metabolic and neurologic side effects of antipsychotics and concerns about the increased risks associated with concomitant use, antipsychotic polypharmacy is a quality concern. This study assessed the operating characteristics of a Medicaid claims-based measure of antipsychotic po...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pharmacoepidemiol Drug Saf
Päätekijät: Leckman-Westin, Emily, Kealey, Edith, Gupta, Nitin, Chen, Qingxian, Gerhard, Tobias, Crystal, Stephen, Olfson, Mark, Finnerty, Molly
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4486331/
https://ncbi.nlm.nih.gov/pubmed/24664793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.3609
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia